Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
There is currently a lack of consensus as to whether defects in natural killer T (NKT) cells contribute to human diseases. Here, the authors explain how contrasting results may have arisen and suggest more stringent methods to improve NKT cell analysis and therapeutic prospects.
This Review describes the recent progress we have made in understanding how regulatory T cell responses are tailored according to the particular nature of the immune environment. The authors discuss the implications for developing new therapies that harness the functions of regulatory T cells.
Adipose tissues and infiltrating immune cells produce numerous bioactive factors that have pro-inflammatory or anti-inflammatory activities. Here, the authors describe how dysregulated production of these so-called adipokines can contribute to the pathogenesis of obesity-linked metabolic disease.
The cellular stresses that are proposed to underlie impaired insulin secretion and sensitivity in type 2 diabetes can also trigger inflammation. Here, the authors explain how inflammatory mechanisms are involved in the pathogenesis of type 2 diabetes and how this knowledge is directing immunomodulatory strategies for treating the disease.
In this Opinion article, David Finlay and Doreen Cantrell explore the molecular pathways that may link CD8+ T cell metabolism with effector versus memory CD8+T cell differentiation through the control of T cell migration.
